Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Thrombosis leads to early termination of phase II BAY-1093884 trial

Feb. 10, 2020

First-in-human data show safety and early hemostatic efficacy of BAY-2599023

Feb. 10, 2020

Verseon divulges new thrombin inhibitors

Feb. 4, 2020

Initial first-in-human data presented for OTL-102

Feb. 4, 2020

Bayer presents data from the phase II FOXTROT study of osocimab

Feb. 3, 2020

Janssen presents phase II results for daratumumab in relapsed AL amyloidosis

Jan. 29, 2020

Results from phase I/II COMPOSER study of crovalimab

Jan. 29, 2020

Young blood not all it's cracked up to be

Jan. 22, 2020

Long-term safety and efficacy of AAV5-hFVIII-SQ gene therapy

Jan. 17, 2020

Nomacopan achieves primary endpoint at interim analysis of phase III CAPSTONE study

Jan. 13, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...